Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2016 1
2017 1
2018 1
2019 1
2020 2
2021 1
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Nanobodies-Useful Tools for Allergy Treatment?
Flicker S, Zettl I, Tillib SV. Flicker S, et al. Among authors: tillib sv. Front Immunol. 2020 Sep 30;11:576255. doi: 10.3389/fimmu.2020.576255. eCollection 2020. Front Immunol. 2020. PMID: 33117377 Free PMC article. Review.
Properties of Fluorescent Far-Red Anti-TNF Nanobodies.
Gorshkova EN, Efimov GA, Ermakova KD, Vasilenko EA, Yuzhakova DV, Shirmanova MV, Mokhonov VV, Tillib SV, Nedospasov SA, Astrakhantseva IV. Gorshkova EN, et al. Among authors: tillib sv. Antibodies (Basel). 2018 Dec 15;7(4):43. doi: 10.3390/antib7040043. Antibodies (Basel). 2018. PMID: 31544893 Free PMC article.
VHH-Based Bispecific Antibodies Targeting Cytokine Production.
Nosenko MA, Atretkhany KN, Mokhonov VV, Efimov GA, Kruglov AA, Tillib SV, Drutskaya MS, Nedospasov SA. Nosenko MA, et al. Among authors: tillib sv. Front Immunol. 2017 Sep 1;8:1073. doi: 10.3389/fimmu.2017.01073. eCollection 2017. Front Immunol. 2017. PMID: 28919896 Free PMC article.
Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment.
Zettl I, Ivanova T, Zghaebi M, Rutovskaya MV, Ellinger I, Goryainova O, Kollárová J, Villazala-Merino S, Lupinek C, Weichwald C, Drescher A, Eckl-Dorna J, Tillib SV, Flicker S. Zettl I, et al. Among authors: tillib sv. Front Immunol. 2022 Nov 9;13:1022418. doi: 10.3389/fimmu.2022.1022418. eCollection 2022. Front Immunol. 2022. PMID: 36439110 Free PMC article.
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source.
Efimov GA, Kruglov AA, Khlopchatnikova ZV, Rozov FN, Mokhonov VV, Rose-John S, Scheller J, Gordon S, Stacey M, Drutskaya MS, Tillib SV, Nedospasov SA. Efimov GA, et al. Among authors: tillib sv. Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3006-11. doi: 10.1073/pnas.1520175113. Epub 2016 Mar 2. Proc Natl Acad Sci U S A. 2016. PMID: 26936954 Free PMC article.
14 results